Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-863 drug-drug interaction study in healthy Japanese male volunteers
jRCT2071260070Phase 1Recruiting
- Sponsor
- Nippon Shinyaku
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of NS-863 (4 arms), sponsored by Nippon Shinyaku. Primary endpoints: AUC0-t of NS-863, Cmax of NS-863 and 2 more. Started Aug 2026; status: recruiting.
02
Drugs
NS-863
Beyond the preview
Go deeper on jRCT2071260070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260070.